Glycomet Trio 2 Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg) Tablet SR – Trusted Exporter, Wholesaler & Global Supplier from India | GlobMedIndia
Glycomet Trio 2 Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg) Tablet SR
Glycomet Trio 2 Tablet SR is a triple-combination antidiabetic medication containing Glimepiride 2mg, Metformin 500mg, and Voglibose 0.2mg. It is widely prescribed for the effective management of Type 2 Diabetes Mellitus in patients who require enhanced glycemic control. This sustained-release formulation helps regulate fasting and post-meal blood sugar levels while improving insulin sensitivity and reducing carbohydrate absorption.
GlobMedIndia – The Medicine Exporter is a trusted international pharmaceutical supplier providing fast, safe, and secure worldwide doorstep delivery of medicines. We specialize in exporting life-saving and critical care medicines, including anti-cancer drugs, targeted therapies, injectables, and specialty pharmaceuticals across global markets. We ensure authentic, high-quality, and temperature-controlled pharmaceutical delivery directly from India to patients, hospitals, and healthcare providers worldwide.
Contact Details
WhatsApp: +91 9730316395
Phone: +91 9730316395
Email: info@globmedindia.com
Website: https://globmedsindia.com
About Glycomet Trio 2 Tablet SR
Glycomet Trio 2 combines three clinically proven antidiabetic medicines:
Glimepiride 2mg – Stimulates insulin secretion from pancreatic beta cells.
Metformin 500mg – Reduces glucose production in the liver and improves insulin sensitivity.
Voglibose 0.2mg – Delays carbohydrate digestion and absorption, reducing postprandial blood glucose spikes.
The sustained-release technology provides prolonged therapeutic action and improved patient compliance.
Uses of Glycomet Trio 2 Tablet SR
Glycomet Trio 2 is commonly prescribed for:
Type 2 Diabetes Mellitus
Blood sugar management
Post-meal glucose control
Insulin resistance management
Long-term diabetic care
Glycemic control improvement
Prevention of diabetes-related complications
Benefits of Glycomet Trio 2 Tablet SR
Triple-action diabetes therapy
Effective fasting and postprandial glucose control
Improved insulin utilization
Reduced carbohydrate absorption
Sustained-release formulation
Enhanced patient compliance
Long-term diabetes management support
Why Choose GlobMedIndia?
GlobMedIndia is a leading pharmaceutical exporter, wholesaler, retailer, and supplier serving hospitals, pharmacies, distributors, healthcare providers, and importers worldwide.
Our Key Advantages
Genuine pharmaceutical products
Competitive wholesale pricing
Bulk order fulfillment
Worldwide export services
Temperature-controlled logistics
Secure packaging and handling
Fast international delivery
Export documentation support
Reliable global supply chain
Global Export Markets
We export Glycomet Trio 2 Tablet SR to:
United States of America
Canada
Europe
Middle East
Africa
Southeast Asia
Latin America
Australia
Trusted Glycomet Trio 2 tablet exporter from India to the United States
Wholesale supplier of Glimepiride Metformin Voglibose tablets in California
Reliable diabetes medicine exporter to hospitals and pharmacies in Los Angeles
Glycomet Trio 2 distributor for healthcare providers in Chicago
Affordable Type 2 diabetes medicines from India to the USA
Triple combination diabetes medicine supplier in Houston and Dallas
Pharmaceutical exporter of antidiabetic medicines to Washington State
Glycomet Trio 2 bulk supplier for American distributors
International supplier of sustained-release diabetes tablets
Global exporter of Glimepiride Metformin Voglibose combination medicines
Order Glycomet Trio 2 Tablet SR from GlobMedIndia
GlobMedIndia is committed to delivering authentic, high-quality pharmaceutical products worldwide. Whether you are a distributor, importer, pharmacy, hospital, healthcare provider, or government procurement agency, we offer dependable pharmaceutical export solutions tailored to your needs.
Contact us today for wholesale inquiries, bulk orders, distributor partnerships, and international pharmaceutical exports.
